Skip to Main Content

Paper Details

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Nat Commun
159
2020
3D-cultured cell lines, FAK, FN1, HIF-1, HIF1A, ITGA5, LOX, RNA, Src, TNBC, TNBC tumors, breast cancer, chemoresistant xenografts, collagen, fibronectin, lysyl, lysyl oxidase, miR-142-3p, patients, syngeneic tumors, triple negative breast cancer, tumor
Author NameAffiliation
Carolyn E BanisterUniversity of South Carolina
Carolyn E BanisterUniversity of South Carolina
Phillip BuckhaultsUniversity of South Carolina
Phillip BuckhaultsUniversity of South Carolina
  • 1 - 4

Datasets

Release 1.2